Regulatory Considerations in Development of Amorphous Solid Dispersions
- 22 November 2014
- book chapter
- Published by Springer Nature
- p. 545-563
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Dissolution testing of amorphous solid dispersionsInternational Journal of Pharmaceutics, 2013
- Assessing the performance of amorphous solid dispersionsJournal of Pharmaceutical Sciences, 2012
- Influence of solvent evaporation rate and formulation factors on solid dispersion physical stabilityEuropean Journal of Pharmaceutical Sciences, 2011
- Investigation of Atypical Dissolution Behavior of an Encapsulated Amorphous Solid DispersionJournal of Pharmaceutical Sciences, 2011
- Physical Stability Studies of Miscible Amorphous Solid DispersionsJournal of Pharmaceutical Sciences, 2010
- Use of Artificial Stomach−Duodenum Model for Investigation of Dosing Fluid Effect on Clinical Trial VariabilityMolecular Pharmaceutics, 2010
- Drug–Polymer Solubility and Miscibility: Stability Consideration and Practical Challenges in Amorphous Solid Dispersion DevelopmentJournal of Pharmaceutical Sciences, 2010
- Novel methods for the assessment of miscibility of amorphous drug-polymer dispersionsJournal of Pharmaceutical Sciences, 2009
- Glassy state of pharmaceuticals. IV. Studies on glassy pharmaceuticals by thermomechanical analysis.Chemical and Pharmaceutical Bulletin, 1989
- Difference in physico-pharmaceutical properties between crystalline and noncrystalline 9,3"-diacetylmidecamycin.Chemical and Pharmaceutical Bulletin, 1981